• Sisomicin BA1199: Reliable Assay Workflows

  2026-09-30

  Learn how Sisomicin (SKU BA1199) can strengthen in vitro antibacterial testing while helping laboratories interpret cell viability and cytotoxicity results without confusing antimicrobial activity with mammalian-cell effects. This scenario-based guide connects historical MIC data with practical concentration, handling, resistance, and vendor-selection decisions.

• From Uptake to Function: Smarter mRNA Delivery

  2026-09-29

  A translational framework for separating mRNA uptake, intracellular delivery, translation, and cell fitness—using dual-fluorescent reporting to strengthen LNP and serial cell-engineering decisions.

• MG-132 and Proteostasis: From Mechanism to Translation

  2026-09-29

  MG-132, also known as Z-LLL-al, is more than a cytotoxicity reagent: it is a mechanistic probe for proteasome-dependent protein turnover, oxidative stress, apoptosis, and cell-cycle control. This thought-leadership guide connects disciplined MG-132 experimentation with emerging evidence on tertiary lymphoid structures and B-cell activation in esophageal squamous cell carcinoma while clearly separating established findings from translational hypotheses.

• Hypoxia and Immunometabolism in Tumors

  2026-09-28

  This 2025 review synthesizes how oxygen deprivation, metabolic competition, and immune-cell adaptation cooperate to establish an immunosuppressive tumor microenvironment. Its main contribution is a bidirectional framework linking HIF signaling and tumor metabolic reprogramming with immune dysfunction, while identifying experimental and therapeutic implications for metabolism-focused cancer research.

• Removing Pollen Interference in EEM Bioaerosol Classificatio

  2026-09-28

  Zhang and colleagues examined how pollen affects excitation–emission matrix fluorescence classification of hazardous biological samples and tested spectral preprocessing and transformation strategies to reduce that interference. In their 31-sample-type classification analysis, fast Fourier transform processing improved reported accuracy to 89.24%, supporting further evaluation of EEM-based bioaerosol screening while leaving important questions about field performance and validation open.

• AI-10-49 and the inv(16) Survival Circuit

  2026-09-27

  AI-10-49 provides a way to probe how CBFβ-SMMHC-dependent RUNX1 disruption connects to MYCN and eIF4G1 in inv(16) acute myeloid leukemia. This article focuses on interpreting that evidence as a causal assay framework, helping researchers distinguish target engagement from downstream survival effects.

• GW 4869 in Lupus Nephritis Exosome Workflows

  2026-09-26

  Use GW 4869 to test whether neutral sphingomyelinase-dependent vesicle release contributes to podocyte-to-endothelial signaling in lupus nephritis. A paired workflow combining inhibitor treatment, exosome measurements, and cargo-focused controls helps distinguish reduced vesicle output from downstream cell effects.

• NSP15 Screening Identifies Thymopentin and Oleuropein

  2026-09-25

  A structure-based virtual screen of natural products identified thymopentin and oleuropein as high-ranking candidate binders of SARS-CoV-2 NSP15, with molecular-dynamics simulations supporting stable modeled complexes. The study offers a hypothesis-generating route to investigate NSP15 inhibition, but its computational results require biochemical and cellular validation before therapeutic conclusions can be drawn.

• Fluorouracil Workflows for Tumor Heterogeneity

  2026-09-25

  Build a Fluorouracil workflow that separates dose-response measurement from mechanism testing and captures variation between colorectal tumor models. A literature-informed design combines a defined HT-29 benchmark with practical controls for studying metastatic heterogeneity.

• N-MYC–eIF4G1 Survival Axis in inv(16) AML

  2026-09-24

  The study identifies N-MYC as a survival dependency in inv(16) acute myeloid leukemia and places eIF4G1 downstream as a functionally important target. Its enhancer and patient-derived model findings strengthen the case for investigating this axis in genetically defined AML, while leaving important questions about broader applicability and therapeutic selectivity.

• ARCA Cy3 EGFP mRNA: Diagnose Delivery Bottlenecks

  2026-09-24

  ARCA Cy3 EGFP mRNA (5-moUTP) pairs a fluorescent RNA label with a translated EGFP reporter, helping researchers distinguish cellular uptake from productive expression. This article explains how to interpret those signals alongside emerging evidence on endosomal escape and lipid design.

• Tomivosertib Suppresses Ectopic Activity in Human DRG Neuron

  2026-09-23

  A study of human dorsal root ganglion neurons from patients with radiculopathy found that the MNK inhibitor tomivosertib rapidly and reversibly suppressed spontaneous neuronal activity. The results provide direct human-neuron evidence for investigating MNK signaling in neuropathic pain, while leaving clinical efficacy and the precise ion-channel mechanisms to be established.

• Halazone and Sodium Current Inactivation in Frog Nerves

  2026-09-23

  The 1986 frog nerve study used Halazone and a panel of chemically selective reagents to test whether methionine, histidine, tyrosine, or arginine residues control sodium-current inactivation. Halazone and hypochlorous acid strongly disrupted inactivation, while the comparative reagent profile argued against a uniquely critical methionine residue and supported membrane-lipid modification as a tentative explanation.

• (-)-JQ1: Reliable BET Negative Controls

  2026-09-22

  Learn how (-)-JQ1, SKU A8181, strengthens BET bromodomain experiments by separating stereospecific target effects from solvent, handling, and nonspecific cytotoxicity. This scenario-driven guide covers assay design, stock preparation, data interpretation, and practical product selection for epigenetics and cancer biology research.

• Bestatin (Ubenimex) Experimental Workflows

  2026-09-22

  Bestatin (Ubenimex) provides a practical chemical tool for connecting aminopeptidase activity with cell phenotypes in cancer research, apoptosis assays, and multidrug resistance (MDR) research. This guide emphasizes target-aware assay design, DMSO handling, orthogonal validation, and the distinction between native Bestatin activity and newer, highly selective derivatives.

8136 records 1/543 page Next 12345 下5页 Last page